{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:53:56Z","timestamp":1790949236935,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/nrrheum.2017.201","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T05:47:46Z","timestamp":1512625666000},"page":"19-31","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["The role of semaphorins in immune responses and autoimmune rheumatic diseases"],"prefix":"10.1038","volume":"14","author":[{"given":"Masayuki","family":"Nishide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"key":"BFnrrheum2017201_CR1","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/0092-8674(93)90625-Z","volume":"75","author":"AL Kolodkin","year":"1993","unstructured":"Kolodkin, A. L., Matthes, D. J. & Goodman, C. S. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75, 1389\u20131399 (1993).","journal-title":"Cell"},{"key":"BFnrrheum2017201_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/ncb1193","volume":"6","author":"T Toyofuku","year":"2004","unstructured":"Toyofuku, T. et al. Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat. Cell Biol. 6, 1204\u20131211 (2004).","journal-title":"Nat. Cell Biol."},{"key":"BFnrrheum2017201_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1126\/science.1105416","volume":"307","author":"C Gu","year":"2005","unstructured":"Gu, C. et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307, 265\u2013268 (2005).","journal-title":"Science"},{"key":"BFnrrheum2017201_CR4","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1172\/JCI42118","volume":"120","author":"A Casazza","year":"2010","unstructured":"Casazza, A. et al. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J. Clin. Invest. 120, 2684\u20132698 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2017201_CR5","first-page":"3356","volume":"119","author":"F Maione","year":"2009","unstructured":"Maione, F. et al. Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J. Clin. Invest. 119, 3356\u20133372 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2017201_CR6","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1172\/JCI58976","volume":"122","author":"F Maione","year":"2012","unstructured":"Maione, F. et al. Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice. J. Clin. Invest. 122, 1832\u20131848 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2017201_CR7","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/nm.2489","volume":"17","author":"T Negishi-Koga","year":"2011","unstructured":"Negishi-Koga, T. et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat. Med. 17, 1473\u20131480 (2011).","journal-title":"Nat. Med."},{"key":"BFnrrheum2017201_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/ncb1416","volume":"8","author":"N Takegahara","year":"2006","unstructured":"Takegahara, N. et al. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat. Cell Biol. 8, 615\u2013622 (2006).","journal-title":"Nat. Cell Biol."},{"key":"BFnrrheum2017201_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nature11000","volume":"485","author":"M Hayashi","year":"2012","unstructured":"Hayashi, M. et al. Osteoprotection by semaphorin 3A. Nature 485, 69\u201374 (2012).","journal-title":"Nature"},{"key":"BFnrrheum2017201_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1101\/gad.184481.111","volume":"26","author":"T Toyofuku","year":"2012","unstructured":"Toyofuku, T. et al. Endosomal sorting by Semaphorin 4A in retinal pigment epithelium supports photoreceptor survival. Genes Dev. 26, 816\u2013829 (2012).","journal-title":"Genes Dev."},{"key":"BFnrrheum2017201_CR11","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/ncomms2420","volume":"4","author":"S Nojima","year":"2013","unstructured":"Nojima, S. et al. A point mutation in Semaphorin 4A associates with defective endosomal sorting and causes retinal degeneration. Nat. Commun. 4, 1406 (2013).","journal-title":"Nat. Commun."},{"key":"BFnrrheum2017201_CR12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4049\/jimmunol.148.2.318","volume":"148","author":"C Bougeret","year":"1992","unstructured":"Bougeret, C. et al. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J. Immunol. 148, 318\u2013323 (1992).","journal-title":"J. Immunol."},{"key":"BFnrrheum2017201_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1074-7613(00)00062-5","volume":"13","author":"A Kumanogoh","year":"2000","unstructured":"Kumanogoh, A. et al. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 13, 621\u2013631 (2000).","journal-title":"Immunity"},{"key":"BFnrrheum2017201_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1074-7613(00)00063-7","volume":"13","author":"W Shi","year":"2000","unstructured":"Shi, W. et al. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity 13, 633\u2013642 (2000).","journal-title":"Immunity"},{"key":"BFnrrheum2017201_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01037","volume":"419","author":"A Kumanogoh","year":"2002","unstructured":"Kumanogoh, A. et al. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 419, 629\u2013633 (2002).","journal-title":"Nature"},{"key":"BFnrrheum2017201_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.immuni.2005.01.014","volume":"22","author":"A Kumanogoh","year":"2005","unstructured":"Kumanogoh, A. et al. Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1\/Th2 regulation in Sema4A-deficient mice. Immunity 22, 305\u2013316 (2005).","journal-title":"Immunity"},{"key":"BFnrrheum2017201_CR17","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/nature05652","volume":"446","author":"K Suzuki","year":"2007","unstructured":"Suzuki, K. et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses through \u03b11\u03b21 integrin. Nature 446, 680\u2013684 (2007).","journal-title":"Nature"},{"key":"BFnrrheum2017201_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/ni.1885","volume":"11","author":"H Takamatsu","year":"2010","unstructured":"Takamatsu, H. et al. Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nat. Immunol. 11, 594\u2013600 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2017201_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ni1553","volume":"9","author":"K Suzuki","year":"2008","unstructured":"Suzuki, K., Kumanogoh, A. & Kikutani, H. Semaphorins and their receptors in immune cell interactions. Nat. Immunol. 9, 17\u201323 (2008).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2017201_CR20","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nri3545","volume":"13","author":"A Kumanogoh","year":"2013","unstructured":"Kumanogoh, A. & Kikutani, H. Immunological functions of the neuropilins and plexins as receptors for semaphorins. Nat. Rev. Immunol. 13, 802\u2013814 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2017201_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrn3302","volume":"13","author":"RJ Pasterkamp","year":"2012","unstructured":"Pasterkamp, R. J. Getting neural circuits into shape with semaphorins. Nat. Rev. Neurosci. 13, 605\u2013618 (2012).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrrheum2017201_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.it.2012.01.008","volume":"33","author":"H Takamatsu","year":"2012","unstructured":"Takamatsu, H. & Kumanogoh, A. Diverse roles for semaphorin-plexin signaling in the immune system. Trends Immunol. 33, 127\u2013135 (2012).","journal-title":"Trends Immunol."},{"key":"BFnrrheum2017201_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ccr.2012.06.031","volume":"22","author":"L Tamagnone","year":"2012","unstructured":"Tamagnone, L. Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer. Cancer Cell 22, 145\u2013152 (2012).","journal-title":"Cancer Cell"},{"key":"BFnrrheum2017201_CR24","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/art.20110","volume":"50","author":"LE Miller","year":"2004","unstructured":"Miller, L. E. et al. Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 50, 1156\u20131163 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017201_CR25","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.4049\/jimmunol.0903527","volume":"185","author":"A Catalano","year":"2010","unstructured":"Catalano, A. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis. J. Immunol. 185, 6373\u20136383 (2010).","journal-title":"J. Immunol."},{"key":"BFnrrheum2017201_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2474-14-40","volume":"14","author":"S Takagawa","year":"2013","unstructured":"Takagawa, S. et al. Decreased semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis. BMC Musculoskelet. Disord. 14, 40 (2013).","journal-title":"BMC Musculoskelet. Disord."},{"key":"BFnrrheum2017201_CR27","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/art.38425","volume":"66","author":"C Gras","year":"2014","unstructured":"Gras, C. et al. Secreted semaphorin 5A activates immune effector cells and is a biomarker for rheumatoid arthritis. Arthritis Rheumatol. 66, 1461\u20131471 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum2017201_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s13075-015-0846-4","volume":"17","author":"SP Chapoval","year":"2015","unstructured":"Chapoval, S. P. Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis. Arthritis Res. Ther. 17, 313 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2017201_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13075-015-0734-y","volume":"17","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Expression of Semaphorin 4A and its potential role in rheumatoid arthritis. Arthritis Res. Ther. 17, 227 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2017201_CR30","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/art.39086","volume":"67","author":"Y Yoshida","year":"2015","unstructured":"Yoshida, Y. et al. Semaphorin 4D contributes to rheumatoid arthritis by inducing inflammatory cytokine production: pathogenic and therapeutic implications. Arthritis Rheumatol 67, 1481\u20131490 (2015).","journal-title":"Arthritis Rheumatol"},{"key":"BFnrrheum2017201_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13075-016-1217-5","volume":"19","author":"J Xie","year":"2017","unstructured":"Xie, J. & Wang, H. Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis. Arthritis Res. Ther. 19, 10 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2017201_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08916930601118890","volume":"40","author":"S Nakano","year":"2007","unstructured":"Nakano, S. et al. Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis. Autoimmunity 40, 9\u201315 (2007).","journal-title":"Autoimmunity"},{"key":"BFnrrheum2017201_CR33","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1177\/0961203311417034","volume":"20","author":"Z Vadasz","year":"2011","unstructured":"Vadasz, Z. et al. The involvement of immune semaphorins and neuropilin-1 in lupus nephritis. Lupus 20, 1466\u20131473 (2011).","journal-title":"Lupus"},{"key":"BFnrrheum2017201_CR34","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1177\/0961203312456753","volume":"21","author":"Z Vadasz","year":"2012","unstructured":"Vadasz, Z. & Toubi, E. Semaphorin 3A \u2014 a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus. Lupus 21, 1266\u20131270 (2012).","journal-title":"Lupus"},{"key":"BFnrrheum2017201_CR35","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.semarthrit.2013.11.010","volume":"43","author":"Z Vadasz","year":"2014","unstructured":"Vadasz, Z. et al. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus. Semin. Arthritis Rheum. 43, 767\u2013771 (2014).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum2017201_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.clim.2016.02.004","volume":"164","author":"Z Vadasz","year":"2016","unstructured":"Vadasz, Z. et al. Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis. Clin. Immunol. 164, 114\u2013118 (2016).","journal-title":"Clin. Immunol."},{"key":"BFnrrheum2017201_CR37","first-page":"370","volume":"97","author":"H Gao","year":"2017","unstructured":"Gao, H. et al. Expression and clinical significance of Semaphorin 3A in serum and mononuclear cells in patients with systemic lupus erythematosus [Chinese]. Zhonghua Yi Xue Za Zhi 97, 370\u2013374 (2017).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"BFnrrheum2017201_CR38","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1002\/art.30386","volume":"63","author":"Y Gan","year":"2011","unstructured":"Gan, Y. et al. Role of semaphorin 7a signaling in transforming growth factor \u03b21-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum. 63, 2484\u20132494 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017201_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/08916934.2010.541171","volume":"44","author":"A Besliu","year":"2011","unstructured":"Besliu, A. et al. Peripheral blood lymphocytes analysis detects CD100\/SEMA4D alteration in systemic sclerosis patients. Autoimmunity 44, 427\u2013436 (2011).","journal-title":"Autoimmunity"},{"key":"BFnrrheum2017201_CR40","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00296-015-3269-2","volume":"35","author":"D Rimar","year":"2015","unstructured":"Rimar, D. et al. Semaphorin 3A: an immunoregulator in systemic sclerosis. Rheumatol. Int. 35, 1625\u20131630 (2015).","journal-title":"Rheumatol. Int."},{"key":"BFnrrheum2017201_CR41","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1136\/annrheumdis-2016-210706","volume":"76","author":"M Nishide","year":"2017","unstructured":"Nishide, M. et al. Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis. Ann. Rheum. Dis. 76, 1440\u20131448 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017201_CR42","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1002\/art.38036","volume":"65","author":"G Xie","year":"2013","unstructured":"Xie, G. et al. Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum. 65, 2457\u20132468 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017201_CR43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13075-015-0749-4","volume":"17","author":"C Mazzotta","year":"2015","unstructured":"Mazzotta, C. et al. Plexin-D1\/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis. Arthritis Res. Ther. 17, 221 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2017201_CR44","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2005-06-2445","volume":"107","author":"A Catalano","year":"2006","unstructured":"Catalano, A. et al. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood 107, 3321\u20133329 (2006).","journal-title":"Blood"},{"key":"BFnrrheum2017201_CR45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/intimm\/dxn006","volume":"20","author":"M Yamamoto","year":"2008","unstructured":"Yamamoto, M. et al. Plexin-A4 negatively regulates T lymphocyte responses. Int. Immunol. 20, 413\u2013420 (2008).","journal-title":"Int. Immunol."},{"key":"BFnrrheum2017201_CR46","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1084\/jem.20101138","volume":"207","author":"H Wen","year":"2010","unstructured":"Wen, H., Lei, Y., Eun, S. Y. & Ting, J. P. Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor- and sepsis-induced cytokine storm. J. Exp. Med. 207, 2943\u20132957 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2017201_CR47","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/intimm\/dxv014","volume":"27","author":"N Yamashita","year":"2015","unstructured":"Yamashita, N. et al. Anti-Semaphorin 3A neutralization monoclonal antibody prevents sepsis development in lipopolysaccharide-treated mice. Int. Immunol. 27, 459\u2013466 (2015).","journal-title":"Int. Immunol."},{"key":"BFnrrheum2017201_CR48","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.immuni.2008.10.008","volume":"29","author":"YI Choi","year":"2008","unstructured":"Choi, Y. I. et al. PlexinD1 glycoprotein controls migration of positively selected thymocytes into the medulla. Immunity 29, 888\u2013898 (2008).","journal-title":"Immunity"},{"key":"BFnrrheum2017201_CR49","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.4049\/jimmunol.1601514","volume":"198","author":"H Movassagh","year":"2017","unstructured":"Movassagh, H., Shan, L., Mohammed, A., Halayko, A. J. & Gounni, A. S. Semaphorin 3E deficiency exacerbates airway inflammation, hyperresponsiveness, and remodeling in a mouse model of allergic asthma. J. Immunol. 198, 1805\u20131814 (2017).","journal-title":"J. Immunol."},{"key":"BFnrrheum2017201_CR50","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ajpath.2017.03.008","volume":"187","author":"H Movassagh","year":"2017","unstructured":"Movassagh, H. et al. Semaphorin 3E alleviates hallmarks of house dust mite-induced allergic airway disease. Am. J. Pathol. 187, 1566\u20131576 (2017).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum2017201_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0092-8674(00)80063-X","volume":"99","author":"L Tamagnone","year":"1999","unstructured":"Tamagnone, L. et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99, 71\u201380 (1999).","journal-title":"Cell"},{"key":"BFnrrheum2017201_CR52","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.immuni.2012.05.026","volume":"37","author":"DA Witherden","year":"2012","unstructured":"Witherden, D. A. et al. The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal \u03b3\u03b4 T cell function. Immunity 37, 314\u2013325 (2012).","journal-title":"Immunity"},{"key":"BFnrrheum2017201_CR53","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature12428","volume":"501","author":"GM Delgoffe","year":"2013","unstructured":"Delgoffe, G. M. et al. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature 501, 252\u2013256 (2013).","journal-title":"Nature"},{"key":"BFnrrheum2017201_CR54","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s12038-015-9566-9","volume":"40","author":"HY Peng","year":"2015","unstructured":"Peng, H. Y., Gao, W., Chong, F. R., Liu, H. Y. & Zhang, J. I. Semaphorin 4A enhances lung fibrosis through activation of Akt via PlexinD1 receptor. J. Biosci. 40, 855\u2013862 (2015).","journal-title":"J. Biosci."},{"key":"BFnrrheum2017201_CR55","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/sj.emboj.7601589","volume":"26","author":"T Toyofuku","year":"2007","unstructured":"Toyofuku, T. et al. Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J. 26, 1373\u20131384 (2007).","journal-title":"EMBO J."},{"key":"BFnrrheum2017201_CR56","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.4049\/jimmunol.177.7.4311","volume":"177","author":"PD Rennert","year":"2006","unstructured":"Rennert, P. D. et al. T cell, Ig domain, mucin domain-2 gene-deficient mice reveal a novel mechanism for the regulation of Th2 immune responses and airway inflammation. J. Immunol. 177, 4311\u20134321 (2006).","journal-title":"J. Immunol."},{"key":"BFnrrheum2017201_CR57","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.intimp.2013.08.005","volume":"17","author":"G Mogie","year":"2013","unstructured":"Mogie, G. et al. Neuroimmune semaphorin 4A as a drug and drug target for asthma. Int. Immunopharmacol. 17, 568\u2013575 (2013).","journal-title":"Int. Immunopharmacol."},{"key":"BFnrrheum2017201_CR58","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.4049\/jimmunol.1003485","volume":"186","author":"Y Nakagawa","year":"2011","unstructured":"Nakagawa, Y. et al. Identification of semaphorin 4B as a negative regulator of basophil-mediated immune responses. J. Immunol. 186, 2881\u20132888 (2011).","journal-title":"J. Immunol."},{"key":"BFnrrheum2017201_CR59","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/intimm\/dxg098","volume":"15","author":"I Ishida","year":"2003","unstructured":"Ishida, I. et al. Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses. Int. Immunol. 15, 1027\u20131034 (2003).","journal-title":"Int. Immunol."},{"key":"BFnrrheum2017201_CR60","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.1097545","volume":"305","author":"I Oinuma","year":"2004","unstructured":"Oinuma, I., Ishikawa, Y., Katoh, H. & Negishi, M. The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 305, 862\u2013865 (2004).","journal-title":"Science"},{"key":"BFnrrheum2017201_CR61","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/intimm\/dxh307","volume":"17","author":"A Kumanogoh","year":"2005","unstructured":"Kumanogoh, A. et al. Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment. Int. Immunol. 17, 1277\u20131282 (2005).","journal-title":"Int. Immunol."},{"key":"BFnrrheum2017201_CR62","doi-asserted-by":"publisher","first-page":"11780","DOI":"10.1073\/pnas.93.21.11780","volume":"93","author":"KT Hall","year":"1996","unstructured":"Hall, K. T. et al. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc. Natl Acad. Sci. USA 93, 11780\u201311785 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2017201_CR63","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1182\/blood-2002-05-1339","volume":"101","author":"L Granziero","year":"2003","unstructured":"Granziero, L. et al. CD100\/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes. Blood 101, 1962\u20131969 (2003).","journal-title":"Blood"},{"key":"BFnrrheum2017201_CR64","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.4049\/jimmunol.169.3.1175","volume":"169","author":"A Kumanogoh","year":"2002","unstructured":"Kumanogoh, A. et al. Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells. J. Immunol. 169, 1175\u20131181 (2002).","journal-title":"J. Immunol."},{"key":"BFnrrheum2017201_CR65","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.4049\/jimmunol.0902450","volume":"184","author":"TR Kataoka","year":"2010","unstructured":"Kataoka, T. R., Kumanogoh, A., Bandara, G., Metcalfe, D. D. & Gilfillan, A. M. CD72 negatively regulates KIT-mediated responses in human mast cells. J. Immunol. 184, 2468\u20132475 (2010).","journal-title":"J. Immunol."},{"key":"BFnrrheum2017201_CR66","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1523\/JNEUROSCI.4390-03.2004","volume":"24","author":"JL Goldberg","year":"2004","unstructured":"Goldberg, J. L. et al. An oligodendrocyte lineage-specific semaphorin, Sema5A, inhibits axon growth by retinal ganglion cells. J. Neurosci. 24, 4989\u20134999 (2004).","journal-title":"J. Neurosci."},{"key":"BFnrrheum2017201_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mvr.2009.10.005","volume":"79","author":"A Sadanandam","year":"2010","unstructured":"Sadanandam, A., Rosenbaugh, E. G., Singh, S., Varney, M. & Singh, R. K. Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis. Microvasc. Res. 79, 1\u20139 (2010).","journal-title":"Microvasc. Res."},{"key":"BFnrrheum2017201_CR68","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.neuron.2011.06.009","volume":"71","author":"RL Matsuoka","year":"2011","unstructured":"Matsuoka, R. L. et al. Class 5 transmembrane semaphorins control selective Mammalian retinal lamination and function. Neuron 71, 460\u2013473 (2011).","journal-title":"Neuron"},{"key":"BFnrrheum2017201_CR69","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/sj.embor.7400189","volume":"5","author":"S Artigiani","year":"2004","unstructured":"Artigiani, S. et al. Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep. 5, 710\u2013714 (2004).","journal-title":"EMBO Rep."},{"key":"BFnrrheum2017201_CR70","doi-asserted-by":"publisher","first-page":"13015","DOI":"10.1073\/pnas.0803386105","volume":"105","author":"BP O'Connor","year":"2008","unstructured":"O'Connor, B. P. et al. Semaphorin 6D regulates the late phase of CD4+ T cell primary immune responses. Proc. Natl Acad. Sci. USA 105, 13015\u201313020 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2017201_CR71","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nature01790","volume":"424","author":"RJ Pasterkamp","year":"2003","unstructured":"Pasterkamp, R. J., Peschon, J. J., Spriggs, M. K. & Kolodkin, A. L. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 424, 398\u2013405 (2003).","journal-title":"Nature"},{"key":"BFnrrheum2017201_CR72","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/art.27243","volume":"62","author":"JS Kong","year":"2010","unstructured":"Kong, J. S. et al. Anti-neuropilin-1 peptide inhibition of synoviocyte survival, angiogenesis, and experimental arthritis. Arthritis Rheum. 62, 179\u2013190 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017201_CR73","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/1078-0432.CCR-15-0431","volume":"22","author":"A Patnaik","year":"2016","unstructured":"Patnaik, A. et al. Safety, pharmacokinetics, and pharmacodynamics of a humanized anti-Semaphorin 4D antibody, in a first-in-human study of patients with advanced solid tumors. Clin. Cancer Res. 22, 827\u2013836 (2016).","journal-title":"Clin. Cancer Res."},{"key":"BFnrrheum2017201_CR74","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1212\/NXI.0000000000000367","volume":"4","author":"C LaGanke","year":"2017","unstructured":"LaGanke, C. et al. Safety\/tolerability of the anti-semaphorin 4D antibody VX15\/2503 in a randomized phase 1 trial. Neurol. Neuroimmunol. Neuroinflamm 4, e367 (2017).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"BFnrrheum2017201_CR75","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1084\/jem.20072602","volume":"205","author":"JR Sierra","year":"2008","unstructured":"Sierra, J. R. et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J. Exp. Med. 205, 1673\u20131685 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2017201_CR76","doi-asserted-by":"publisher","first-page":"e1054599","DOI":"10.1080\/2162402X.2015.1054599","volume":"4","author":"EE Evans","year":"2015","unstructured":"Evans, E. E., Paris, M., Smith, E. S. & Zauderer, M. Immunomodulation of the tumor microenvironment by neutralization of Semaphorin 4D. Oncoimmunology 4, e1054599 (2015).","journal-title":"Oncoimmunology"},{"key":"BFnrrheum2017201_CR77","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/351662a0","volume":"351","author":"H Van de Velde","year":"1991","unstructured":"Van de Velde, H., von Hoegen, I., Luo, W., Parnes, J. R. & Thielemans, K. The B-cell surface protein CD72\/Lyb-2 is the ligand for CD5. Nature 351, 662\u2013665 (1991).","journal-title":"Nature"},{"key":"BFnrrheum2017201_CR78","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1084\/jem.20160560","volume":"213","author":"C Akatsu","year":"2016","unstructured":"Akatsu, C. et al. CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm\/RNP. J. Exp. Med. 213, 2691\u20132706 (2016).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2017201_CR79","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.38367","volume":"66","author":"S Wieczorek","year":"2014","unstructured":"Wieczorek, S. et al. The SEM6A6 locus is not associated with granulomatosis with polyangiitis or other forms of antineutrophil cytoplasmic antibody-associated vasculitides in Europeans: comment on the article by Xie et al. Arthritis Rheumatol. 66, 1400\u20131401 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum2017201_CR80","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1681\/ASN.2014050477","volume":"26","author":"A Bertram","year":"2015","unstructured":"Bertram, A. et al. Circulating ADAM17 level reflects disease activity in proteinase-3 ANCA-associated vasculitis. J. Am. Soc. Nephrol. 26, 2860\u20132870 (2015).","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.201","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrrheum.2017.201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T18:53:51Z","timestamp":1693335231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2017.201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFnrrheum2017201"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2017.201","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]},"assertion":[{"value":"7 December 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}